▶ 調査レポート

診断用特殊抗体の世界市場（～2026年）
• 英文タイトル：Global Diagnostic Specialty Antibodies Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。診断用特殊抗体の世界市場（～2026年） / Global Diagnostic Specialty Antibodies Market Size, Status and Forecast 2020-2026 / MRC2-11QY11641資料のイメージです。• レポートコード：MRC2-11QY11641
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Multi User￥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当調査資料は診断用特殊抗体のグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体、ポリクローナル抗体、組換えポリクローナル抗体）市場規模、用途別（病院、診断研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別診断用特殊抗体の競争状況、市場シェア
・世界の診断用特殊抗体市場：種類別市場規模 2015年-2020年（モノクローナル抗体、ポリクローナル抗体、組換えポリクローナル抗体）
・世界の診断用特殊抗体市場：種類別市場規模予測 2021年-2026年（モノクローナル抗体、ポリクローナル抗体、組換えポリクローナル抗体）
・世界の診断用特殊抗体市場：用途別市場規模 2015年-2020年（病院、診断研究所、その他）
・世界の診断用特殊抗体市場：用途別市場規模予測 2021年-2026年（病院、診断研究所、その他）
・北米の診断用特殊抗体市場分析：米国、カナダ
・ヨーロッパの診断用特殊抗体市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの診断用特殊抗体市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の診断用特殊抗体市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの診断用特殊抗体市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Sanofi、Roche、Abbott Laboratories、Bio-Rad Laboratories、Boehringer Ingelheim、Agilent Technologies、Abcam、Aytu BioScience
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Diagnostic Specialty Antibodies Market
The global Diagnostic Specialty Antibodies market size is projected to reach US$ 20750 million by 2026, from US$ 20090 million in 2020, at a CAGR of 3.0%% during 2021-2026.

Global Diagnostic Specialty Antibodies Scope and Market Size
Diagnostic Specialty Antibodies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diagnostic Specialty Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Sanofi
Roche
Abbott Laboratories
Bio-Rad Laboratories
Boehringer Ingelheim
Agilent Technologies
Abcam
Aytu BioScience

Market segment by Type, the product can be split into
Monoclonal Antibodies
Polyclonal Antibodies
Recombinant Polyclonal Antibodies
Market segment by Application, split into
Hospitals
Diagnostic Laboratories
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Diagnostic Specialty Antibodies Revenue
1.4 Market by Type
1.4.1 Global Diagnostic Specialty Antibodies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibodies
1.4.3 Polyclonal Antibodies
1.4.4 Recombinant Polyclonal Antibodies
1.5 Market by Application
1.5.1 Global Diagnostic Specialty Antibodies Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostic Laboratories
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Diagnostic Specialty Antibodies Market Perspective (2015-2026)
2.2 Global Diagnostic Specialty Antibodies Growth Trends by Regions
2.2.1 Diagnostic Specialty Antibodies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Diagnostic Specialty Antibodies Historic Market Share by Regions (2015-2020)
2.2.3 Diagnostic Specialty Antibodies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Diagnostic Specialty Antibodies Market Growth Strategy
2.3.6 Primary Interviews with Key Diagnostic Specialty Antibodies Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Diagnostic Specialty Antibodies Players by Market Size
3.1.1 Global Top Diagnostic Specialty Antibodies Players by Revenue (2015-2020)
3.1.2 Global Diagnostic Specialty Antibodies Revenue Market Share by Players (2015-2020)
3.1.3 Global Diagnostic Specialty Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Diagnostic Specialty Antibodies Market Concentration Ratio
3.2.1 Global Diagnostic Specialty Antibodies Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Diagnostic Specialty Antibodies Revenue in 2019
3.3 Diagnostic Specialty Antibodies Key Players Head office and Area Served
3.4 Key Players Diagnostic Specialty Antibodies Product Solution and Service
3.5 Date of Enter into Diagnostic Specialty Antibodies Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Diagnostic Specialty Antibodies Historic Market Size by Type (2015-2020)
4.2 Global Diagnostic Specialty Antibodies Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Diagnostic Specialty Antibodies Market Size by Application (2015-2020)
5.2 Global Diagnostic Specialty Antibodies Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Diagnostic Specialty Antibodies Market Size (2015-2020)
6.2 Diagnostic Specialty Antibodies Key Players in North America (2019-2020)
6.3 North America Diagnostic Specialty Antibodies Market Size by Type (2015-2020)
6.4 North America Diagnostic Specialty Antibodies Market Size by Application (2015-2020)

7 Europe
7.1 Europe Diagnostic Specialty Antibodies Market Size (2015-2020)
7.2 Diagnostic Specialty Antibodies Key Players in Europe (2019-2020)
7.3 Europe Diagnostic Specialty Antibodies Market Size by Type (2015-2020)
7.4 Europe Diagnostic Specialty Antibodies Market Size by Application (2015-2020)

8 China
8.1 China Diagnostic Specialty Antibodies Market Size (2015-2020)
8.2 Diagnostic Specialty Antibodies Key Players in China (2019-2020)
8.3 China Diagnostic Specialty Antibodies Market Size by Type (2015-2020)
8.4 China Diagnostic Specialty Antibodies Market Size by Application (2015-2020)

9 Japan
9.1 Japan Diagnostic Specialty Antibodies Market Size (2015-2020)
9.2 Diagnostic Specialty Antibodies Key Players in Japan (2019-2020)
9.3 Japan Diagnostic Specialty Antibodies Market Size by Type (2015-2020)
9.4 Japan Diagnostic Specialty Antibodies Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Diagnostic Specialty Antibodies Market Size (2015-2020)
10.2 Diagnostic Specialty Antibodies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Diagnostic Specialty Antibodies Market Size by Type (2015-2020)
10.4 Southeast Asia Diagnostic Specialty Antibodies Market Size by Application (2015-2020)

11 India
11.1 India Diagnostic Specialty Antibodies Market Size (2015-2020)
11.2 Diagnostic Specialty Antibodies Key Players in India (2019-2020)
11.3 India Diagnostic Specialty Antibodies Market Size by Type (2015-2020)
11.4 India Diagnostic Specialty Antibodies Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Diagnostic Specialty Antibodies Market Size (2015-2020)
12.2 Diagnostic Specialty Antibodies Key Players in Central & South America (2019-2020)
12.3 Central & South America Diagnostic Specialty Antibodies Market Size by Type (2015-2020)
12.4 Central & South America Diagnostic Specialty Antibodies Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Diagnostic Specialty Antibodies Introduction
13.1.4 Sanofi Revenue in Diagnostic Specialty Antibodies Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview
13.2.3 Roche Diagnostic Specialty Antibodies Introduction
13.2.4 Roche Revenue in Diagnostic Specialty Antibodies Business (2015-2020)
13.2.5 Roche Recent Development
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Details
13.3.2 Abbott Laboratories Business Overview
13.3.3 Abbott Laboratories Diagnostic Specialty Antibodies Introduction
13.3.4 Abbott Laboratories Revenue in Diagnostic Specialty Antibodies Business (2015-2020)
13.3.5 Abbott Laboratories Recent Development
13.4 Bio-Rad Laboratories
13.4.1 Bio-Rad Laboratories Company Details
13.4.2 Bio-Rad Laboratories Business Overview
13.4.3 Bio-Rad Laboratories Diagnostic Specialty Antibodies Introduction
13.4.4 Bio-Rad Laboratories Revenue in Diagnostic Specialty Antibodies Business (2015-2020)
13.4.5 Bio-Rad Laboratories Recent Development
13.5 Boehringer Ingelheim
13.5.1 Boehringer Ingelheim Company Details
13.5.2 Boehringer Ingelheim Business Overview
13.5.3 Boehringer Ingelheim Diagnostic Specialty Antibodies Introduction
13.5.4 Boehringer Ingelheim Revenue in Diagnostic Specialty Antibodies Business (2015-2020)
13.5.5 Boehringer Ingelheim Recent Development
13.6 Agilent Technologies
13.6.1 Agilent Technologies Company Details
13.6.2 Agilent Technologies Business Overview
13.6.3 Agilent Technologies Diagnostic Specialty Antibodies Introduction
13.6.4 Agilent Technologies Revenue in Diagnostic Specialty Antibodies Business (2015-2020)
13.6.5 Agilent Technologies Recent Development
13.7 Abcam
13.7.1 Abcam Company Details
13.7.2 Abcam Business Overview
13.7.3 Abcam Diagnostic Specialty Antibodies Introduction
13.7.4 Abcam Revenue in Diagnostic Specialty Antibodies Business (2015-2020)
13.7.5 Abcam Recent Development
13.8 Aytu BioScience
13.8.1 Aytu BioScience Company Details
13.8.2 Aytu BioScience Business Overview
13.8.3 Aytu BioScience Diagnostic Specialty Antibodies Introduction
13.8.4 Aytu BioScience Revenue in Diagnostic Specialty Antibodies Business (2015-2020)
13.8.5 Aytu BioScience Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Diagnostic Specialty Antibodies Key Market Segments
Table 2. Key Players Covered: Ranking by Diagnostic Specialty Antibodies Revenue
Table 3. Ranking of Global Top Diagnostic Specialty Antibodies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Diagnostic Specialty Antibodies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monoclonal Antibodies
Table 6. Key Players of Polyclonal Antibodies
Table 7. Key Players of Recombinant Polyclonal Antibodies
Table 8. Global Diagnostic Specialty Antibodies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Diagnostic Specialty Antibodies Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Diagnostic Specialty Antibodies Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Diagnostic Specialty Antibodies Market Share by Regions (2015-2020)
Table 12. Global Diagnostic Specialty Antibodies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Diagnostic Specialty Antibodies Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Diagnostic Specialty Antibodies Market Growth Strategy
Table 18. Main Points Interviewed from Key Diagnostic Specialty Antibodies Players
Table 19. Global Diagnostic Specialty Antibodies Revenue by Players (2015-2020) (Million US$)
Table 20. Global Diagnostic Specialty Antibodies Market Share by Players (2015-2020)
Table 21. Global Top Diagnostic Specialty Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Specialty Antibodies as of 2019)
Table 22. Global Diagnostic Specialty Antibodies by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Diagnostic Specialty Antibodies Product Solution and Service
Table 25. Date of Enter into Diagnostic Specialty Antibodies Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Diagnostic Specialty Antibodies Market Size by Type (2015-2020) (Million US$)
Table 28. Global Diagnostic Specialty Antibodies Market Size Share by Type (2015-2020)
Table 29. Global Diagnostic Specialty Antibodies Revenue Market Share by Type (2021-2026)
Table 30. Global Diagnostic Specialty Antibodies Market Size Share by Application (2015-2020)
Table 31. Global Diagnostic Specialty Antibodies Market Size by Application (2015-2020) (Million US$)
Table 32. Global Diagnostic Specialty Antibodies Market Size Share by Application (2021-2026)
Table 33. North America Key Players Diagnostic Specialty Antibodies Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Diagnostic Specialty Antibodies Market Share (2019-2020)
Table 35. North America Diagnostic Specialty Antibodies Market Size by Type (2015-2020) (Million US$)
Table 36. North America Diagnostic Specialty Antibodies Market Share by Type (2015-2020)
Table 37. North America Diagnostic Specialty Antibodies Market Size by Application (2015-2020) (Million US$)
Table 38. North America Diagnostic Specialty Antibodies Market Share by Application (2015-2020)
Table 39. Europe Key Players Diagnostic Specialty Antibodies Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Diagnostic Specialty Antibodies Market Share (2019-2020)
Table 41. Europe Diagnostic Specialty Antibodies Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Diagnostic Specialty Antibodies Market Share by Type (2015-2020)
Table 43. Europe Diagnostic Specialty Antibodies Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Diagnostic Specialty Antibodies Market Share by Application (2015-2020)
Table 45. China Key Players Diagnostic Specialty Antibodies Revenue (2019-2020) (Million US$)
Table 46. China Key Players Diagnostic Specialty Antibodies Market Share (2019-2020)
Table 47. China Diagnostic Specialty Antibodies Market Size by Type (2015-2020) (Million US$)
Table 48. China Diagnostic Specialty Antibodies Market Share by Type (2015-2020)
Table 49. China Diagnostic Specialty Antibodies Market Size by Application (2015-2020) (Million US$)
Table 50. China Diagnostic Specialty Antibodies Market Share by Application (2015-2020)
Table 51. Japan Key Players Diagnostic Specialty Antibodies Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Diagnostic Specialty Antibodies Market Share (2019-2020)
Table 53. Japan Diagnostic Specialty Antibodies Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Diagnostic Specialty Antibodies Market Share by Type (2015-2020)
Table 55. Japan Diagnostic Specialty Antibodies Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Diagnostic Specialty Antibodies Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Diagnostic Specialty Antibodies Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Diagnostic Specialty Antibodies Market Share (2019-2020)
Table 59. Southeast Asia Diagnostic Specialty Antibodies Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Diagnostic Specialty Antibodies Market Share by Type (2015-2020)
Table 61. Southeast Asia Diagnostic Specialty Antibodies Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Diagnostic Specialty Antibodies Market Share by Application (2015-2020)
Table 63. India Key Players Diagnostic Specialty Antibodies Revenue (2019-2020) (Million US$)
Table 64. India Key Players Diagnostic Specialty Antibodies Market Share (2019-2020)
Table 65. India Diagnostic Specialty Antibodies Market Size by Type (2015-2020) (Million US$)
Table 66. India Diagnostic Specialty Antibodies Market Share by Type (2015-2020)
Table 67. India Diagnostic Specialty Antibodies Market Size by Application (2015-2020) (Million US$)
Table 68. India Diagnostic Specialty Antibodies Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Diagnostic Specialty Antibodies Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Diagnostic Specialty Antibodies Market Share (2019-2020)
Table 71. Central & South America Diagnostic Specialty Antibodies Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Diagnostic Specialty Antibodies Market Share by Type (2015-2020)
Table 73. Central & South America Diagnostic Specialty Antibodies Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Diagnostic Specialty Antibodies Market Share by Application (2015-2020)
Table 75. Sanofi Company Details
Table 76. Sanofi Business Overview
Table 77. Sanofi Product
Table 78. Sanofi Revenue in Diagnostic Specialty Antibodies Business (2015-2020) (Million US$)
Table 79. Sanofi Recent Development
Table 80. Roche Company Details
Table 81. Roche Business Overview
Table 82. Roche Product
Table 83. Roche Revenue in Diagnostic Specialty Antibodies Business (2015-2020) (Million US$)
Table 84. Roche Recent Development
Table 85. Abbott Laboratories Company Details
Table 86. Abbott Laboratories Business Overview
Table 87. Abbott Laboratories Product
Table 88. Abbott Laboratories Revenue in Diagnostic Specialty Antibodies Business (2015-2020) (Million US$)
Table 89. Abbott Laboratories Recent Development
Table 90. Bio-Rad Laboratories Company Details
Table 91. Bio-Rad Laboratories Business Overview
Table 92. Bio-Rad Laboratories Product
Table 93. Bio-Rad Laboratories Revenue in Diagnostic Specialty Antibodies Business (2015-2020) (Million US$)
Table 94. Bio-Rad Laboratories Recent Development
Table 95. Boehringer Ingelheim Company Details
Table 96. Boehringer Ingelheim Business Overview
Table 97. Boehringer Ingelheim Product
Table 98. Boehringer Ingelheim Revenue in Diagnostic Specialty Antibodies Business (2015-2020) (Million US$)
Table 99. Boehringer Ingelheim Recent Development
Table 100. Agilent Technologies Company Details
Table 101. Agilent Technologies Business Overview
Table 102. Agilent Technologies Product
Table 103. Agilent Technologies Revenue in Diagnostic Specialty Antibodies Business (2015-2020) (Million US$)
Table 104. Agilent Technologies Recent Development
Table 105. Abcam Company Details
Table 106. Abcam Business Overview
Table 107. Abcam Product
Table 108. Abcam Revenue in Diagnostic Specialty Antibodies Business (2015-2020) (Million US$)
Table 109. Abcam Recent Development
Table 110. Aytu BioScience Business Overview
Table 111. Aytu BioScience Product
Table 112. Aytu BioScience Company Details
Table 113. Aytu BioScience Revenue in Diagnostic Specialty Antibodies Business (2015-2020) (Million US$)
Table 114. Aytu BioScience Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diagnostic Specialty Antibodies Market Share by Type: 2020 VS 2026
Figure 2. Monoclonal Antibodies Features
Figure 3. Polyclonal Antibodies Features
Figure 4. Recombinant Polyclonal Antibodies Features
Figure 5. Global Diagnostic Specialty Antibodies Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Diagnostic Laboratories Case Studies
Figure 8. Others Case Studies
Figure 9. Diagnostic Specialty Antibodies Report Years Considered
Figure 10. Global Diagnostic Specialty Antibodies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Diagnostic Specialty Antibodies Market Share by Regions: 2020 VS 2026
Figure 12. Global Diagnostic Specialty Antibodies Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Diagnostic Specialty Antibodies Market Share by Players in 2019
Figure 15. Global Top Diagnostic Specialty Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Specialty Antibodies as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Diagnostic Specialty Antibodies Revenue in 2019
Figure 17. North America Diagnostic Specialty Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Diagnostic Specialty Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Diagnostic Specialty Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Diagnostic Specialty Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Diagnostic Specialty Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Diagnostic Specialty Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Diagnostic Specialty Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

以下、関連資料のご紹介
  • モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年）
    Global Monoclonal antibodies (mAbs) Biosimilars Market Size, Status and Forecast 2020-2026
    MRC2-11QY03843 2020年11月20日 90Pages
    当調査資料はモノクローナル抗体(mAb)バイオシミラーのグローバル市場について調査・分析したレポートです。種類別（エリスロポエチン（EPO）、ヒト成長ホルモン（HGH）、顆粒球コロニー刺激因子（G-CSF）、モノクローナル抗体（mAb）、インスリン、インターフェロン（IFN）、その他）市場規模、用途...
  • 風疹診断検査の世界市場（～2026年）
    Global Rubella Diagnostic Testing Market Size, Status and Forecast 2020-2026
    MRC2-11QY04539 2020年11月20日 99Pages
    当調査資料は風疹診断検査のグローバル市場について調査・分析したレポートです。種類別（フローサイトメトリー、ラテックススライド凝集反応、モノクローナル抗体、イムノアッセイ、血清学的検査、臨床評価）市場規模、用途別（病院、商業、診療所、保健所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ド...
  • 神経科学抗体・アッセイの世界市場（～2026年）
    Global Neuroscience Antibodies and Assays Market Size, Status and Forecast 2020-2026
    MRC2-11QY03959 2020年11月20日 95Pages
    当調査資料は神経科学抗体・アッセイのグローバル市場について調査・分析したレポートです。種類別（消耗品、機器）市場規模、用途別（製薬・バイオテクノロジー企業、学術・研究所、病院・診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、...
  • 大腸菌（Eコリ）診断検査の世界市場（～2026年）
    Global Escherichia Coli (E. Coli) Diagnostic Testing Market Size, Status and Forecast 2020-2026
    MRC2-11QY11883 2020年11月25日 132Pages
    当調査資料は大腸菌（Eコリ）診断検査のグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体、分子診断、微分光散乱、イムノアッセイ、フローサイトメトリー、クロマトグラフィー、画像診断）市場規模、用途別（商業/私立研究所、病院、公衆衛生研究所、学術研究所）市場規模、地域別（北米、...
  • 子宮頸がん診断検査の世界市場（～2026年）
    Global Cervical Cancer Diagnostic Test Market Size, Status and Forecast 2020-2026
    MRC2-11QY11329 2020年11月25日 93Pages
    当調査資料は子宮頸がん診断検査のグローバル市場について調査・分析したレポートです。種類別（コルポスコピー、生検、パパニコロウ試験、HPV検査）市場規模、用途別（病院、専門クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓...
  • 肝炎診断検査の世界市場（～2026年）
    Global Hepatitis Diagnostic Test Market Size, Status and Forecast 2020-2026
    MRC2-11QY12170 2020年11月25日 97Pages
    当調査資料は肝炎診断検査のグローバル市場について調査・分析したレポートです。種類別（血液検査、画像検査、肝生検）市場規模、用途別（病院、商業/民間研究所、血液銀行、診療所、公衆衛生研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中...
  • HER2抗体の世界市場（～2026年）
    Global HER2 Antibodies Market Size, Status and Forecast 2020-2026
    MRC2-11QY12175 2020年11月25日 90Pages
    当調査資料はHER2抗体のグローバル市場について調査・分析したレポートです。種類別（トラスツズマブ、ラパチニブ、アド-トラスツズマブエムタンシン、ペルツズマブ、エベロリムス）市場規模、用途別（病院薬局、小売薬局、Eコマース）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス...
  • 治療用組換え抗体・タンパク質の世界市場（～2026年）
    Global Recombinant Therapeutic Antibodies and Proteins Market Size, Status and Forecast 2020-2026
    MRC2-11QY04472 2020年11月20日 91Pages
    当調査資料は治療用組換え抗体・タンパク質のグローバル市場について調査・分析したレポートです。種類別（血漿たんぱく質、融合たんぱく質、モノクローナル抗体、ホルモン、酵素、凝固因子、その他）市場規模、用途別（腫瘍学、血液学、免疫学、内分泌学、感染症、心血管疾患、その他）市場規模、地域別（北米、米国、カナ...
  • IVD（体外診断）検査の世界市場（～2026年）
    Global IVD (In Vitro Diagnostic) Testing Market Size, Status and Forecast 2020-2026
    MRC2-11QY12449 2020年11月25日 92Pages
    当調査資料はIVD（体外診断）検査のグローバル市場について調査・分析したレポートです。種類別（ポイントオブケア診断、免疫化学診断、臨床化学診断、分子診断、血液診断機器、微生物診断、血液診断機器、ヘモスタシス診断）市場規模、用途別（病院、外来手術センター、診断センター、その他）市場規模、地域別（北米、...
  • 髄膜炎診断検査の世界市場（～2026年）
    Global Meningitis Diagnostic Testing Market Size, Status and Forecast 2020-2026
    MRC2-11QY12651 2020年11月25日 97Pages
    当調査資料は髄膜炎診断検査のグローバル市場について調査・分析したレポートです。種類別（ラテックス凝集試験、PCRアッセイ、ラテラルフローアッセイ、培養試験、ELISA試験）市場規模、用途別（病院・クリニック、診断センター、研究センター、学術医療センター）市場規模、地域別（北米、米国、カナダ、ヨーロッ...
  • モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年）モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年） A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of q…
  • 治療用組換え抗体・タンパク質の世界市場（～2026年）治療用組換え抗体・タンパク質の世界市場（～2026年） Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…
  • 神経科学抗体・アッセイの世界市場（～2026年）神経科学抗体・アッセイの世界市場（～2026年） The demand for Neuroscience Antibodies and Assays is increasing, due to the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. Market Analysis and Insights: Global Neuroscience Antibodies and Assa…
  • 癌治療用モノクローナル抗体の世界市場（～2026年）癌治療用モノクローナル抗体の世界市場（～2026年） The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from oth…
  • HER2抗体の世界市場（～2026年）HER2抗体の世界市場（～2026年） The demand of HER2 Antibodies is increasing, and primarily gaining from growing awareness regarding the prevalence of HER2 positive breast cancer. Market Analysis and Insights: Global HER2 Antibodies Market The global HER2 Antibodies market size is projected to reach US$ 8543.4 million by 2026, from…